Katherine Fuh

13PUBLICATIONS
122CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 12, 2026
In vivo genome-wide CRISPR screens of human T cells in solid tumours.

|Jul 13, 2026
Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline, Version 2026.1.0.

|Jul 10, 2026
Aging increases ovarian cancer growth, metastasis, and immunosuppression that can be alleviated by inhibiting hedgehog signaling.

|Sep 04, 2025
DDR2 Confers Ferroptosis Resistance to Cancer-Associated Fibroblasts and Attenuates PARPi Sensitivity of Ovarian Tumor Cells.

Julien Lesage, Alessandra DiMauro, Angela M Schab

|Jul 22, 2025
Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response.

Mark C Valentine, Mary M Mullen, Emilee N Kotnik

|Jul 02, 2025
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.

Tianyi Liu, Meng Zhang, Tatyanah Farsh

Pageof 3

Frequent Collaborators

5 joint publications

Gregory D Longmore

3 joint publications

Mary M Mullen

2 joint publications

Lindsay M Kuroki

2 joint publications

Andrea R Hagemann